Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 5/20 | 0.36 |
| ▸ | CA1 | P00915 | 5/20 | 0.36 |
| ▸ | CA9 | Q16790 | 5/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3595767 | 0.85 | ALDH1A1 (0.41) | ALDH1A1TP53SMN1; SMN2CYP3A4ALOX15 | |
| SCHEMBL4877716 | 0.84 | KAT6A (0.36) | ALDH1A1TP53SMN1; SMN2KAT6ACA12 | |
| SCHEMBL4880814 | 0.84 | KAT6A (0.41) | ALDH1A1TP53SMN1; SMN2ALOX15KAT6A | |
| SCHEMBL12559946 | 0.81 | ALDH1A1 (0.55) | ALDH1A1TP53SMN1; SMN2CYP3A4ALOX15 | |
| SCHEMBL1553874 | 0.78 | ALDH1A1 (0.42) | ALDH1A1TP53SMN1; SMN2CYP3A4ALOX15 | |
| SCHEMBL14201394 | 0.76 | KAT6A (0.43) | ALDH1A1SMN1; SMN2KAT6ACA12CA1 | |
| SCHEMBL3963684 | 0.76 | KAT6A (0.45) | ALDH1A1TP53SMN1; SMN2KAT6AGAA | |
| SCHEMBL17204539 | 0.76 | GAA (0.40) | ALDH1A1SMN1; SMN2KAT6ACA12CA1 | |
| SCHEMBL8385349 | 0.76 | ALDH1A1 (0.48) | ALDH1A1TP53SMN1; SMN2CYP3A4KAT6A | |
| SCHEMBL12658254 | 0.76 | MAPT (0.38) | ALDH1A1SMN1; SMN2TSHRKAT6ACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807596-B2 | Thiol compounds, synthesis method therefor, and utilization of said thiol compounds | SHIKOKU CHEMICALS CORPORATION (JP) | 2023-11-07 | — | — | US | disclosed |
| US-11807596-B2 | Thiol compounds, synthesis method therefor, and utilization of said thiol compounds | SHIKOKU CHEMICALS CORPORATION (JP) | 2023-11-07 | — | — | US | disclosed |
| US-20200369606-A1 | THIOL COMPOUNDS, SYNTHESIS METHOD THEREFOR, AND UTILIZATION OF SAID THIOL COMPOUNDS | SHIKOKU CHEMICALS CORPORATION (JP) | 2020-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200369606-A1 | THIOL COMPOUNDS, SYNTHESIS METHOD THEREFOR, AND UTILIZATION OF SAID THIOL COMPOUNDS | TMT1A, CTH, SLC7A11 | ALDH1A1 81/4885TP53 3602/4885SMN1; SMN2 4687/4885 |
| US-11807596-B2 | Thiol compounds, synthesis method therefor, and utilization of said thiol compounds | TMT1A, CTH, SLC7A11 | ALDH1A1 81/4885TP53 3602/4885SMN1; SMN2 4687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.